American Society of Clinical Oncology

SHERPA: White

People

  1. Dickson
    Dickson
  2. Tap
    Tap
  3. D'Angelo
    D'Angelo
  4. Gounder
    Gounder
  5. Keohan
    Keohan
  6. Antonescu
    Antonescu
  7. Qin
    Qin
  8. Abramson
    Abramson
  9. Bluth
    Bluth
  10. Gordon
    Gordon

Groups

  1. Department of Medicine (14)
  2. Sarcoma Service (14)
  3. Solid Tumor Oncology Division (14)
  4. GSK Faculty (6)
  5. Biostatistics Service (5)
  6. Epidemiology and Biostatistics (5)
  7. Hematologic Malignancies, Division of (5)
  8. Nursing (4)
  9. Radiology, Department of (4)
  10. Surgery (4)
Search Within
  1. "2012"
  2. "Sarcoma Service"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (1)
Groups
  1. Department of Medicine (14)
  2. Sarcoma Service (14)
  3. Solid Tumor Oncology Division (14)
  4. GSK Faculty (6)
  5. Biostatistics Service (5)
  6. Epidemiology and Biostatistics (5)

More Groups

People
  1. Gary Schwartz (10)
  2. Mark Dickson (7)
  3. Richard Carvajal (7)
  4. William Tap (7)
  5. Mary Keohan (5)
  6. Mrinal Gounder (5)

More People

Years
  1. 2012 (14)
Publications
  1. Journal of Clinical Oncology (14)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase Ib/II study evaluating the efficacy of doxorubicin (D) with or without a human anti-PDGFR alpha monoclonal antibody olaratumab (IMC-3G3) in the treatment of advanced soft tissue sarcoma (STS)
    Meeting Abstract

    Tap, W. D.; Van Tine, B. A.; Elias, A. D.; Livingston, M. B.; Agulnik, M.; Cooney, M. M.; Chmielowski, B.; Brenner, A. J.; Pennock, G. K.; Somaiah, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II multicenter study of the IGF-1 receptor antibody cixutumumab (A12) and the mTOR inhibitor temsirolimus (TEM) in patients (pts) with refractory IGF-1R positive (+) and negative (-) bone and soft tissue sarcomas (STS)
    Meeting Abstract

    Schwartz, G. K.; Tap, W. D.; Qin, L. X.; Livingston, M. B.; Undevia, S. D.; Chmielowski, B.; Agulnik, M.; Schuetze, S.; Reed, D. R.; Okuno, S. H.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg)
    Meeting Abstract

    Postow, M. A.; Yuan, J.; Panageas, K.; Bogatch, K.; Callahan, M.; Cheng, M.; Schroeder, S. E. A.; Kendle, R. F.; Harding, J. J.; Dickson, M. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A first-in-human, phase Ib combination study to assess safety, pharmacokinetics (PK), and pharmacodynamics (PD) of a hedgehog inhibitor, GDC-0449, with a Notch inhibitor, RO4929097, in patients with advanced sarcoma
    Meeting Abstract

    Gounder, M. M.; Dickson, M. A.; Wu, N.; Ivy, S. P.; Carvajal, R. D.; D'Angelo, S. P.; Keohan, M. L.; Qin, L. X.; Erinjeri, J. P.; Takebe, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Keohan, M. L.; Tap, W. D.; Antonescu, C.; Landa, J.; Qin, L. X.; Dohrenwend, E. G.; Rathbone, D.; Ustoyev, Y.; Condy, M. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A first-in-human phase I study of MORAb-004 (M4), a humanized monoclonal antibody recognizing endosialin (TEM-1), in patients with solid tumors
    Meeting Abstract

    Diaz, L. A.; Azad, N. S.; Gounder, M. M.; Coughlin, C. M.; Fishel, J.; O'Shannessy, D.; Grasso, L.; Wustner, J.; Aluri, J.; Parno, J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Advanced soft-tissue sarcoma in patients over age 75: Patterns of care and survival
    Meeting Abstract

    Decoopman, D. G.; Keohan, M. L.; Cioffi, A.; Maki, R. G.; Nguyen, B. B.; Italiano, A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Activity of sorafenib in radiation-associated breast angiosarcomas harboring MYC and FLT4 amplifications
    Meeting Abstract

    D'Angelo, S. P.; Antonescu, C. R.; Keohan, M. L.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Moraco, N. H.; Singer, S.; Schwartz, G. K.; Tap, W. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized phase III, multicenter, open-label study comparing TH-302 in combination with doxorubicin versus doxorubicin alone in subjects with locally advanced unresectable or metastatic soft tissue sarcoma
    Meeting Abstract

    Chawla, S. P.; Reinke, D. K.; Saks, S.; Kroll, S.; Tap, W. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized multicenter double-blind phase II trial: The immunological adjuvant OPT-821 with or without a trivalent ganglioside vaccine in metastatic sarcoma patients following metastasectomy
    Meeting Abstract

    Carvajal, R. D.; Chugh, R.; Milhem, M. M.; Ryan, C. W.; George, S.; Chmielowski, B.; Agulnik, M.; Rodler, E. T.; Elias, A. D.; Budd, G. T.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save